High concentration of immunoglobulin A is associated with temporal lobe epilepsy

Epilepsy Research

Volumn 103, Issue 1, 2013, Pages 54-61

  Liimatainen, Suvi ^a   Fallah, Mahdi ^a,b   Kharazmi, Elham ^a,b   Haapala, Anna Maija ^c   Isojärvi, Jouko ^d,e   Peltola, Jukka ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

^d UCB PHARMA   (Belgium)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Immunoglobulin; Immunology; Refractory epilepsy; Temporal lobe epilepsy; Topiramate

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMOTRIGINE; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; RETIGABINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BRAIN REGION; CELIAC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; TEMPORAL LOBE EPILEPSY; THYROIDITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BIOLOGICAL MARKERS; COHORT STUDIES; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84872132610     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.06.002     Document Type: Article

References (37)

1. Bartolomei F., Boucraut J., Barrié M., Kok J., Dravet C., Viallat D., Bernard D., Gastaut J.L. Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?. Epilepsia 1996, 37:922-926.
2. Bleck T.P., Smith M.C. Possible induction of systemic lupus erythematosus by valproate. Epilepsia 2009, 31:343-345.
3. Caksen H., Oner A.F., Arslan S., Kan M.C., Cesur Y., Uner A. Immunoglobulin subgroups in children with febrile seizures. Pediatr. Int. 2001, 43:58-60.
4. Callenbach P.M., Jol-Van Der Zijde C.M., Geerts A.T., Arts W.F., Van Donselaar C.A., Peters A.C., Stroink H., Brouwer O.F., Van Tol M.J. Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin. Exp. Immunol. 2003, 132:144-151. Dutch Study of Epilepsy in Childhood.
5. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
6. Crespel A., Coubes P., Rousset M.C., Brana C., Rougier A., Rondouin G., Bockaert J., Baldy-Moulinier M., Lerner-Natoli M. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 2002, 952:159-169.
7. De la Concha E.G., Fernandez-Arquero M., Gual L., Vigil P., Martinez A., Urcelay E., Ferreira A., Garcia-Rodriguez M.C., Fontan G. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J. Immunol. 2002, 169:4637-4643.
8. De Ponti F., Lecchini S., Cosentino M., Castelletti C.M., Malesci A., Frigo G.M. Immunological adverse effects of anticonvulsants. What is their clinical relevance?. Drug Saf. 1993, 8:235-250.
9. Dogné J.M., Thiry A., Pratico D., Masereel B., Supuran C.T. Dual carbonic anhydrase - cyclooxygenase-2 inhibitors. Curr. Top. Med. Chem. 2007, 7:885-891.
10. Eeg-Olofsson O., Osterland C.K., Guttmann R.D., Andermann F., Prchal J.F., Andermann E., Janjua N.A. Immunological studies in focal epilepsy. Acta Neurol. Scand. 1988, 78:358-368.
11. Fontana A., Grob P.J., Sauter R., Joller H. IgA deficiency, epilepsy, and hydantoin medication. Lancet 1976, 2:228-231.
12. Gilhus N.E., Aarli J.A., Thorsby E. HLA antigens in epileptic patients with drug-induced immunodeficiency. Int. J. Immunopharmacol. 1982, 4:517-520.
13. Herranz M.T., Rivier G., Khamashta M.A., Blaser K.U., Hughes G.R. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 1994, 37:568-571.
14. Jain K.K. Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy. Drug Saf. 1991, 6:350-360.
15. Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G., Moshé S.L., Perucca E., Wiebe S., French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.
16. Liimatainen S., Fallah M., Kharazmi E., Peltola M., Peltola J. Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J. Neurol. 2009, 256:796-802.
17. Liimatainen S., Peltola M., Fallah M., Kharazmi E., Haapala A.M., Peltola J. The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur. J. Neurol. 2009, 16:134-141.
18. Liimatainen S., Peltola M., Sabater L., Fallah M., Kharazmi E., Haapala A.M., Dastidar P., Knip M., Saiz A., Peltola J. The clinical significance of glutamic acid decarboxylase antibodies in chronic epilepsy. Epilepsia 2010, 51:760-767.
19. Liimatainen S., Lehtimäki K., Raitala A., Peltola M., Oja S.S., Peltola J., Hurme M.A. Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy. Epilepsy Res. 2011, (Epub March 3).
20. Maeoka Y., Hara T., Dejima S., Takeshita K. IgA and IgG2 deficiency associated with zonisamide therapy: a case report. Epilepsia 1997, 38:611-613.
21. Majoie H.J., de Baets M., Renier W., Lang B., Vincent A. Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res. 2006, 71:135-141.
22. Mutoh K., Hidaka Y., Hirose Y., Kimura M. Possible induction of systemic lupus erythematosus by zonisamide. Pediatr. Neurol. 2001, 25:340-343.
23. Peltola J., Hurme M., Miettinen A., Keränen T. Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 1998, 31:129-133.
24. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., Lindholm D., Keränen T. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 2000, 41:205-211.
25. Peltola J., Haapala A.M., Isojärvi J., Auvinen A., Palmio J., Latvala K., Kulmala P., Laine S., Vaarala O., Keränen T. Antiphosholipid and antinuclear antibodies in epileptic syndromes and newly onset seizure disorders. Am. J. Med. 2000, 109:712-717.
26. Peltola J., Kulmala J., Isojärvi J., Saiz A., Latvala K., Palmio J., Savola K., Knip M., Keränen T., Graus F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000, 12:46-50.
27. Peltola J., Laaksonen J., Haapala A.M., Hurme M., Rainesalo S., Keränen T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 2002, 11:44-46.
28. Ranua J., Luoma K., Auvinen A., Peltola J., Haapala A.M., Raitanen J., Isojärvi J. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study. Epilepsy Behav. 2005, 6:191-195.
29. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
30. Sarzi-Puttini P., Panni B., Cazzola M., Muzzupappa S., Turiel M. Lamotrigine-induced lupus. Lupus 2000, 9:555-557.
31. Seager J., Jamison D.L., Wilson J., Hayward A.R., Soothill J.F. IgA deficiency, epilepsy, and phenytoin treatment. Lancet 1975, 2:632-635.
32. Sorrell T.C., Forbes I.J. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin. Exp. Immunol. 1975, 20:273-285.
33. Sorrell T.C., Forbes I.J., Burness F.R., Rischbieth R.H. Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet 1971, 2:1233-1235.
34. Van Engelen B.G., Weemaes C.M., Renier W.O., Bakkeren J.A., Borm G.F., Strengers P.F. A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome. Scand. J. Immunol. 1995, 41:209-213.
35. Verrot D., San-Marco M., Dravet C., Genton P., Disdier P., Bolla G., Harle J.R., Reynaud L., Weiller P.J. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am. J. Med. 1997, 10:33-37.
36. Virta M., Hurme M., Helminen M. Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 2002, 43:920-923.
37. Woof J.M., Kerr M.A. The function of immunoglobulin A in immunity. J. Pathol. 2002, 208:270-282.